Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Biosensors Market Size Worth USD 21.2 Billion by 2020 | CAGR 7.9%: Grand View Research, Inc.


SAN FRANCISCO, March 22, 2018 /PRNewswire/ --

The global biosensors market is anticipated to reach USD 21.2 billion by 2020, according to a new report by Grand View Research, Inc. Myriad applications in the medical field, rising diabetic population base, high demand for miniature diagnostic devices, and rapid technological advancements are the key factors that are driving the market growth. 

     (Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )

Growing technological developments within all the segments of biosensors are expected to be significant drivers for the growth of biosensors market over the forecast period. For instance, novel advancement in the development of optical quantum dots is expected to provide novel avenues for application in biopharmaceutical development, proteomic analysis, and vaccine development. Similarly, growing applications for thermal biosensors in biomolecular interaction and hybridization analysis, environmental monitoring, and cosmetic analysis are expected to provide the market with greater application opportunities resulting in increased market demand. The development of nano particle based electrochemical biosensors and nanotechnology-based usage contribute to increased importance of this driver over the forecast period.

Moreover, growing worldwide prevalence of diabetes (both type I and type II) is expected to drive market expansion over the forecast period. According to the estimates of the International Diabetes Federation, the global prevalence of diabetes is expected to increase from 425 million in 2017 to 629 million in 2045.

Browse full research report with TOC on "Biosensors Market Size, Share & Trends Analysis Report By Application (Medical, Agriculture) By Technology (Thermal, Electrochemical, Optical) And Segment Forecasts, 2012 - 2020" at: https://www.grandviewresearch.com/industry-analysis/biosensors-market

Further Key Findings From the Report Suggest: 


Browse related reports by Grand View Research: 





Grand View Research has segmented the global biosensors market on the basis of application, technology, end user and region: 


Read Our Blog By Grand View Research: https://www.grandviewresearch.com/blogs/healthcare

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]

Web: https://www.grandviewresearch.com


SOURCE Grand View Research, Inc.


These press releases may also interest you

at 08:05
CG Life specialty marketing communications agency Element CG, formerly The Market Element, today announced a brand relaunch to align more closely with its focus on supporting emerging life sciences and biopharma companies with scientific marketing...

at 08:05
Rubedo Life Sciences, a biotechnology company specializing in cellular senescence and anti-aging research, announced today a multi-year strategic partnership with German multinational beauty company Beiersdorf AG to develop innovative skin care...

at 08:03
OsteoRemedies® LLC, an orthopedic company focused on providing simple solutions to complex disorders, has announced FDA clearance for expanded indications for the SPECTRUM® GV Bone Cement. The expanded indication covers the fixation of revision hip...

at 08:03
Semler Scientific, Inc. , a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the first quarter...

at 08:03
Endevica Bio, a company developing first-in-class peptide drug candidates, announced its novel weight-loss treatment was successful in a recent diet-induced obesity (DIO) rat study....

at 08:01
During National Immunization Awareness Week, Pfizer Canada and McMaster University are proud to announce a significant project aimed at addressing critical gaps in health equity in the development and delivery of vaccines. Pfizer Canada's...



News published on and distributed by: